Receive our newsletter – data, insights and analysis delivered to you
In association with Butterworth Laboratories
  1. Sponsored
October 1, 2021

Experience of Testing Ninhydrin-Positive Substances using Ph.Eur. Monographs

By Miranda Mclaren

By Frank Judge, Consultant Chemist – Chromatography, Butterworth Laboratories

Free Whitepaper
img

Residual Solvents to USP 467 and 1467

In this white paper, British contract research organisation (CRO) Butterworth Labs explores the intricacies in the recently introduced changes to USP 467 and 1467, Residual Solvents. USP 467 replaces 1226 (Validation of Compendial Procedures). A company’s ability to approach changes openly and embrace them quickly sets them apart from the crowd. Download this free white paper to see how your company can benefit from a CRO that understands and embraces all the latest legislation and guidance for clinical trials.
by Butterworth Laboratories
Enter your details here to receive your free Whitepaper.

The main complication with the analysis of amino acids and related substances is due to their low volatility and inability to form active chromophores when in a solution. This means that GC and HPLC using UV/Vis detection are not applicable and other common HPLC detectors lack the required sensitivity.

Most free amino acids and ammonium contain a primary amine functional group, which can be derivatised with ninhydrin to form compounds with a chromophore that absorbs electromagnetic radiation at 570nm, resulting in a deep purple colour. Amino acids with a secondary amine functional group can also be derivatised with ninhydrin; these result in chromophores that absorb at 440nm resulting in a yellow colour. Compounds that react in this way are referred to as ninhydrin-positive substances since they give a positive reaction (i.e. colour change) when derivatised with ninhydrin.

Historically, the Ph. Eur. Amino Acid monographs took advantage of these reactions to determine the levels of ninhydrin-positive substances present as contaminants in various Amino Acid samples using a Thin Layer Chromatography (TLC) procedure. This involved separating sample components by development of the TLC plate, then visualising the analytes by spraying the plate with ninhydrin which reacts with any ninhydrin-positive substances on the plate to give coloured spots. The major problem with this procedure was that it did not resolve all possible ninhydrin-positive substances. The method was also very subjective since quantitation was based on a simple visual comparison of the relative intensity of sample and standard derived spots.

To address the problems with TLC, the Ph. Eur. started revising amino acid monograms in 2014, replacing the TLC requirement with a procedure based on High Performance Liquid Chromatography (HPLC). The new test employed the separation of amino acids on an ion-exchange column with different ionic strength and pH eluents. The resulting stream of separated Amino Acid sample components eluting from the column are mixed with ninhydrin supplied from a secondary pump. The mixed sample and ninhydrin stream is then passed through a heated reaction coil to promote derivatisation of any ninhydrin-positive substances, these can then be detected using a photometer at the wavelengths already specified above. This process is known as ‘post-column ninhydrin derivatisation’. Dedicated instruments capable of post-column ninhydrin derivatisation are commercially available and are known as Amino Acid Analysers (AAA).

Reconfiguring the system

With the requirement change from TLC to HPLC post-column ninhydrin derivatisation, Butterworth decided to reconfigure an existing HPLC system with a secondary pump and heated reaction coil to carry out the analysis. However the system lacked sensitivity and, under certain circumstances, by-products from the derivatisation process form precipitates, blocking the tubing and causing high back pressures. These problems increased instrument down time due to the need for maintenance.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

To negate these and other problems, and reduce uncertainty with analysis reporting times, Butterworth has purchased and validated a Hitachi LA8080 Amino Acid Analyser. The main differences from the previous ad hoc set-up included an increase in sensitivity. The biggest change was the elimination of tubing blocking and increasing analytical column back pressures. At the end of each individual sample analysis, after all amino acids have eluted, a column regeneration mobile phase is pumped prior to a long period of equilibration with initial analytical mobile phase conditions. Another benefit is that the secondary ninhydrin pump operates in 2 channel mode; a start-up and shutdown program is run with every sequence which involves purging the pump and reaction coil with an ethanol solution to dissolve and remove any particulate build-up.

Butterworth has already verified the new system for the analysis of Arginine, Histidine and Tryptophan, and will verify the method for other less frequently requested amino acids when required by clients. In addition our Projects Department are also currently looking at the same testing in the JP Monograph as the result of a client request.

Free Whitepaper
img

Residual Solvents to USP 467 and 1467

In this white paper, British contract research organisation (CRO) Butterworth Labs explores the intricacies in the recently introduced changes to USP 467 and 1467, Residual Solvents. USP 467 replaces 1226 (Validation of Compendial Procedures). A company’s ability to approach changes openly and embrace them quickly sets them apart from the crowd. Download this free white paper to see how your company can benefit from a CRO that understands and embraces all the latest legislation and guidance for clinical trials.
by Butterworth Laboratories
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU